{
    "Project Title": "Not Available",
    "Sponsor": "Hospices Civils de Lyon",
    "Study Number": "Not Available",
    "Protocol Version and Date": "Not Available",
    "Study Title": "Not Available",
    "Phase": "Phase II",
    "Therapeutic Area": "Hereditary Hemorrhagic Telangiectasia (HHT)",
    "Number of Patients": "48",
    "Number of Sites": "Not Available",
    "Indication": "HHT complicated by nosebleeds",
    "Duration of Treatment": "6 weeks",
    "Schedule of Assessments": "Table 1, Section 4.3",
    "questionnaires": [
        {
            "longName": "Epistaxis Severity Score",
            "shortName": "ESS",
            "type": "PRO",
            "questionnaireSchedule": "Inclusion (V1), End of treatment (V2), End of study (V3)",
            "questionnaireTiming": [
                "",
                "Inclusion  V1 J0",
                "V2  D43 (to 50)",
                "V3  D85 (to 100)"
            ]
        },
        {
            "longName": "SF-36 Quality of Life Questionnaire",
            "shortName": "SF-36",
            "type": "PRO",
            "questionnaireSchedule": "Inclusion (V1), End of treatment (V2), End of study (V3)",
            "questionnaireTiming": [
                "Inclusion  V1 J0",
                "V2  D43 (to 50)",
                "V3  D85 (to 100)"
            ]
        },
        {
            "longName": "Nosebleed Monitoring Grids",
            "shortName": "N/A",
            "type": "ObsRO",
            "questionnaireSchedule": "Inclusion (V1), End of treatment (V2), End of study (V3)",
            "questionnaireTiming": [
                "Inclusion  V1 J0",
                "",
                "V2  D43 (to 50)",
                "V3  D85 (to 100)"
            ]
        }
    ]
}